Projects per year
Fingerprint
Dive into the research topics where Julie Marie Vose is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia
Smith, A. L., Eiken, A. P., Skupa, S. A., Moore, D. Y., Umeta, L. T., Smith, L. M., Lyden, E. R., D’angelo, C. R., Kallam, A., Vose, J. M., Kutateladze, T. G. & El-Gamal, D., Jun 1 2022, In: International journal of molecular sciences. 23, 12, 6712.Research output: Contribution to journal › Article › peer-review
Open Access -
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience
Bennani, N. N., Tun, A. M., Carson, K. R., Geiger, J. L., Maeda, L. S., Savage, K. J., Rose, J., Pinter-Brown, L., Lunning, M. A., Abramson, J. S., Bartlett, N. L., Vose, J. M., Evens, A. M., Smith, S. M., Horwitz, S. M., Ansell, S. M. & Advani, R. H., May 1 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, 5, p. e300-e309Research output: Contribution to journal › Article › peer-review
-
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience
Bennani, N. N., Tun, A. M., Carson, K. R., Geiger, J. L., Maeda, L. S., Savage, K. J., Rose, J., Pinter-Brown, L., Lunning, M. A., Abramson, J. S., Bartlett, N. L., Vose, J. M., Evens, A. M., Smith, S. M., Horwitz, S. M., Ansell, S. M. & Advani, R. H., Apr 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, 4, p. e250-e260Research output: Contribution to journal › Article › peer-review
-
CLL-217 Patient Characteristics and Time to Next Treatment With Ibrutinib and Anti-CD20 Monotherapy as First-Line Treatment in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Lu, X., He, J., Ran, T., Wu, L., Panjabi, S. & Vose, J. M., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S273Research output: Contribution to journal › Article › peer-review
-
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS
Herek, T. A., Bouska, A., Lone, W., Sharma, S., Amador, C., Heavican, T. B., Li, Y., Wei, Q., Jochum, D., Greiner, T. C., Smith, L., Pileri, S., Feldman, A. L., Rosenwald, A., Ott, G., Lim, S. T., Ong, C. K., Song, J., Jaffe, E. S., Wang, G. G., & 7 others, Sep 15 2022, In: Blood. 140, 11, p. 1278-1290 13 p.Research output: Contribution to journal › Article › peer-review